Straumann Holding AG
STMN | SW
Overview
Corporate Details
- ISIN(s):
- CH0551990689 (+2 more)
- LEI:
- 50670046ML5FVIM60Z37
- Country:
- Switzerland
- Address:
- Peter Merian-Weg 12, 4002 Basel
- Website:
- https://www.straumann.com/
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
We are a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann conducts research, develops and manufactures dental implants, instruments, prosthetics, tissue and bone regeneration biomaterials for use in tooth replacement and restoration, or to prevent tooth loss. Technological advancements are changing dentistry fundamentally. Straumann offers a broad range of products and solutions for both conventional treatment and digital workflows including guided surgery, intra-oral scanning and CAD/CAM restorations. We share your passion for quality and desire to achieve the best patient outcomes. Groundbreaking and evidence-based innovations are not the only reasons why you can enjoy peace of mind with us. Our highly skilled and motivated team has more than 60 years of experience in business partnering, training and education, and is dedicated to providing global support.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-06 16:26 |
Regulatory News Service
Straumann to invest in Villeret while localizing production for China in Shangh…
|
English | 10.4 KB | |
2025-06-06 02:00 |
Regulatory News Service
Straumann to invest in Villeret while localizing production for China in Shangh…
|
English | 13.9 KB | |
2025-06-06 02:00 |
Regulatory News Service
Straumann investiert in Villeret und verlagert gleichzeitig die Produktion für …
|
German | 15.8 KB | |
2025-04-30 07:00 |
Regulatory News Service
Strong start in an environment marked by macroeconomic uncertainties
|
English | 70.4 KB | |
2025-04-22 19:52 |
Regulatory News Service
Invitation: Straumann Group 2025 first-quarter results webcast
|
English | 3.4 KB | |
2025-04-10 16:36 |
Regulatory News Service
Straumann Group shareholders approve all proposals
|
English | 12.7 KB | |
2025-03-25 07:00 |
Regulatory News Service
Straumann Group to present its advanced digital dentistry end-to-end workflow a…
|
English | 19.9 KB | |
2025-03-08 07:00 |
Board/Management Change
Straumann Group appoints Isabelle Adelt as Chief Financial Officer
|
English | 2.6 KB | |
2025-03-07 07:00 |
Board/Management Change
Straumann Group ernennt Isabelle Adelt zum Chief Financial Officer
|
German | 9.2 KB | |
2025-03-07 01:00 |
Board/Management Change
Straumann Group appoints Isabelle Adelt as Chief Financial Officer
|
English | 10.2 KB | |
2025-03-07 01:00 |
Board/Management Change
Straumann Group ernennt Isabelle Adelt zum Chief Financial Officer
|
German | 11.8 KB | |
2025-02-27 07:00 |
Board/Management Change
Straumann Group announces Executive Management Board changes
|
English | 9.3 KB | |
2025-02-26 07:00 |
Board/Management Change
Straumann Group announces Executive Management Board changes
|
English | 9.3 KB | |
2025-02-26 01:00 |
Board/Management Change
Straumann Group announces Executive Management Board changes
|
English | 11.5 KB | |
2025-02-26 01:00 |
Board/Management Change
Straumann Group kündigt Änderungen in der Geschäftsleitung an
|
German | 13.3 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2025-05-06 | N/A | Non-Executive member | Buy | None | 308,000.00 CHF |
2025-05-06 | N/A | Non-Executive member | Buy | None | 99,980.00 CHF |
2025-05-02 | N/A | Executive member | Buy | None | 199,985.34 CHF |
2025-05-02 | N/A | Executive member | Buy | None | 112,482.57 CHF |
2025-05-02 | N/A | Executive member | Buy | None | 99,992.67 CHF |
2025-05-02 | N/A | Executive member | Buy | None | 97,852.98 CHF |
2025-05-02 | N/A | Executive member | Buy | None | 49,959.60 CHF |
2025-04-25 | N/A | Executive member | Sell | None | 14,105.65 CHF |
2025-04-25 | N/A | Executive member | Sell | None | 2,841.45 CHF |
2025-02-20 | N/A | Executive member | Sell | None | 131,319.60 CHF |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Crossject | France | ALCJ | |
![]() |
CVS GROUP PLC | United Kingdom | CVSG | |
|
Demant | Denmark | DEMANT | |
![]() |
DexTech Medical AB | Sweden | DEX | |
![]() |
Diagnostic Medical Systems | France | ALDMS | |
|
Dignitana AB | Sweden | DIGN | |
|
Doxa AB | Sweden | DOXA | |
|
Draegerwerk AG & Co. KGaA | Germany | DRW8 | |
|
EasyMotionSkin Tec AG | Liechtenstein | EFIT | |
![]() |
ECR MINERALS PLC | United Kingdom | ECR |